A1 Refereed original research article in a scientific journal

Abnormal perinidal cerebral metabolism is associated with symptoms in brain arteriovenous malformation: New insights by a novel approach using oxygen-15 labelled tracers and PET




AuthorsHashio, Atsushi; Ikedo, Taichi; Mori, Hisae; Iida, Hidehiro; Maruyama, Daisuke; Yamagishi, Masayuki; Kitazawa, Yoshiaki; Hattori, Etsuko Yamamoto; Shimonaga, Koji; Hamano, Eika; Yamada, Kiyofumi; Imamura, Hirotoshi; Iihara, Koji; Kataoka, Hiroharu

PublisherSAGE PUBLICATIONS INC

Publishing placeTHOUSAND OAKS

Publication year2025

JournalJournal of Cerebral Blood Flow and Metabolism

Journal name in sourceJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Journal acronymJ CEREBR BLOOD F MET

Number of pages11

ISSN1559-7016

eISSN0271-678X

DOIhttps://doi.org/10.1177/0271678X251369258


Abstract

The mechanisms underlying neurological symptoms, including epilepsy, in unruptured brain arteriovenous malformations (bAVM) remain to be elucidated. The dual-tracer basis function method (DBFM) with single-scan dual-tracer (15O2 and C15O2) approach is a novel PET imaging technique that can evaluate the hemodynamics and metabolism of brain tissue adjacent to the nidus without the influence of abundant vascular radioactivity. We aimed to clarify the relationship between neurological symptoms and hemodynamic and metabolic abnormalities using the DBFM. Cerebral blood volume (CBV), cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2), and oxygen extraction fraction (OEF) were compared between symptomatic and asymptomatic bAVMs and before and after treatment. Among 46 patients with unruptured bAVMs who underwent DBFM, 26 cases were included. While CBV and OEF increased in the perinidus (p < 0.01), CBF and CMRO2 decreased (p < 0.01). Symptoms were significantly associated with higher OEF (symptomatic vs. asymptomatic, ratio of perinidal to contralateral, n = 13 vs. n = 13, 1.07 ± 0.030 vs. 1.01 ± 0.080, p = 0.017). All elevated OEFs in symptomatic bAVMs with therapeutic symptom resolved in post-therapeutic PET imaging. DBFM revealed a higher OEF was associated with symptomatic bAVM. The DBFM potentially aids in predicting post-therapeutic symptom improvement.


Funding information in the publication
The author(s) received no financial support for the research, authorship, and/or publication of this article.


Last updated on 2025-28-08 at 13:46